The sleep apnea devices market has seen considerable growth due to a variety of factors.
•The market size for sleep apnea devices has shown substantial growth over the years. It's projected to increase from $7.94 billion in 2024 to $8.43 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%.
The growth during the historic period can be linked to factors such as the aging population, upsurge in obesity, growing recognition of related health conditions, the worldwide recognition of sleep apnea, and the widespread occurrence of sleep apnea.
The sleep apnea devices market is expected to maintain its strong growth trajectory in upcoming years.
• Strong expansion is anticipated in the sleep apnea devices market in the upcoming years, with a predicted value of "$11.72 billion in 2029 and a compound annual growth rate (CAGR) of 8.6%.
Factors propelling the projected growth during this period include enhancements in home sleep testing, personalized treatment methodologies, increased usage of oral appliances, emphasis on pediatric sleep apnea, improvements in patient compliance, emergence of new markets, and better access. Upcoming trends in this forecast period include the adoption of telemedicine and remote monitoring, development of portable and travel-friendly devices, incorporation of wearable technologies, customization and personalization of treatments, as well as research in implantable devices.
Gain Insights Into The Sleep Apnea Devices Global Market Report 2025 With A Free Sample Report Here:
The escalating incidence of sleep apnea disorders is anticipated to stimulate the expansion of the sleep apnea devices market. Sleep apnea is a potentially fatal sleep condition marked by frequent cessation and resumption of breathing. Devices for sleep apnea are predicted to play a crucial role in the treatment of sleep apnea disorders and prevention of sleep disruptions. The device uses tubing to continuously deliver pressurized air into a sleep mask, thus preventing the patient's airways from caving in. For example, data from the American Medical Association (AMA) in April 2022 indicated that 30 million people in the US suffered from sleep apnea. One out of every fifteen Americans, which is about 6.62% of the total American populace, undergoes some form of sleep apnea, and nearly 30 percent reported having some symptoms. Thus, the escalating incidence of sleep apnea disorders is fueling the sleep apnea device market's expansion.
The sleep apnea devices market covered in this report is segmented –
1) By Product Type: Airway Clearance System, Adaptive Servo-Ventilation (ASV), Positive Airway Pressure (PAP) Devices, Oral Appliances, Oxygen Devices, Sleep Screening Devices, Actigraphy Systems, Polysomnography (PSG) Device, Respiratory Polygraph
2) By Patient Type: Pediatric, Adult, Geriatric
3) By Disease: Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome
4) By End User: Hospital And Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Center, Home Healthcare
Subsegments:
1) By Airway Clearance System: High-Frequency Chest Wall Oscillation (HFCWO) Devices, Positive Expiratory Pressure (PEP) Devices, Mechanical Insufflation-Exsufflation Devices
2) By Adaptive Servo-Ventilation (ASV): Automatic Pressure Adjustment Devices, Device With Variable Pressure Support
3) By Positive Airway Pressure (PAP) Devices: Continuous Positive Airway Pressure (CPAP) Machines, Bi-Level Positive Airway Pressure (BiPAP) Machines
4) By Oral Appliances: Mandibular Advancement Devices (MADs), Tongue-Retaining Devices (TRDs)
5) By Oxygen Devices: Oxygen Concentrators, Portable Oxygen Cylinders
6) By Sleep Screening Devices: Home Sleep Apnea Testing Devices, Screening Questionnaires
7) By Actigraphy Systems: Wearable Sleep Trackers, Non-Wearable Actigraphy Devices
Prominent companies involved in the sleep apnea devices market are concentrating on creating innovative tools like bi-level positive airway pressure to boost patient comfort and strengthen adherence to treatment. Bi-level positive airway pressure (BiPAP) is a form of non-invasive ventilation predominantly utilized in the management of sleep apnea and other respiratory disorders. It offers two pressure levels – a higher one during inhalation (IPAP) to maintain the airway open, and a lower one during exhalation (EPAP) to facilitate easier breathing out. For example, in February 2024, ResMed, a medical device company based in the US, introduced the AirCurve 11 series. This fresh series of Bi-level positive airway pressure (PAP) devices was developed to augment sleep apnea treatment, aiming to elevate patient comfort and increase therapy compliance.
Major companies operating in the sleep apnea devices market include:
• ResMed Inc.
• Fisher And Paykel Healthcare Corporation Limited
• Natus Medical Incorporated
• Compumedics Limited
• Somnoware Healthcare Systems Inc.
• DeVilbiss Healthcare LLC
• Braebon Medical Corporation
• Koninklijke Philips N.V.
• BMC Medical Co. Ltd.
• Lowenstein Medical Technology GmbH Co. KG
• Nihon Kohden Corporation
• Invacare Corporation
• Cadwell Industries Inc.
• Oventus Medical Ltd.
• Inspire Medical Systems Inc.
• Itamar Medical Ltd.
• APEX Medical Corp.
• Drive DeVilbiss Healthcare
• 3B Medical Inc.
• Airing LLC
• Airway Management Inc.
• Bleep LLC
• Circadiance LLC
• GE Healthcare
• HOFFRICHTER GmbH
• Human Design Medical LLC
• ImThera Medical Inc.
• Provent Sleep Therapy LLC
• Resonea Inc.
• Sleepnet Corporation
North America was the largest region in the sleep apnea devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sleep apnea devices market during the forecast period. The regions covered in the sleep apnea devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa